GPT and Decreased liver function: First described in early Chinese publications about COVID-19, it was evident that patients with mild disease had alterations in aspartate aminotransferase (AST)/alanine aminotransferase (ALT) 18.2/19.8%, respectively, and severe patients manifested changes of 39.4/28.1% in these transaminases, well-recognized biomarkers of liver dysfunction (2).